Mesoblast reports Q1 Ryoncil gross revenue $13.2M
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with , delivered to your inbox every week.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
11 hours ago
- USA Today
Over 64,000 pounds of butter recalled over undeclared milk, FDA says
More than 64,000 pounds of butter have been recalled due to potential undeclared milk allergens, according to the U.S. Food and Drug Administration. Food ingredient company Bunge North America recalled 1,800 cases of its NH European Style Butter Blend that were distributed at 12 centers located across the United States and one in Dominican Republic, a July 14 FDA alert reported. The FDA classified the recall under its second-highest risk warning on July 31 warning that consumption could pose temporary or medically reversible adverse health consequences. USA TODAY has reached out to Bunge North America for comment. Based in Chesterfield, Missouri, Bunge North America is an agribusiness that produces and markets multiple food ingredients including corn, wheat, rice, soybeans and feed peas. Which butter products are recalled? The FDA has issued a recall for 64,800 pounds of Bunge North America's NH European Style Butter Blend with: The product was packaged in white paperboard cases each containing 36 blocks. This story has been updated to resolve an inaccuracy in the headline.
Yahoo
12 hours ago
- Yahoo
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Bumped Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 hours ago
- Yahoo
Over 64,000 pounds of butter recalled over undeclared milk, FDA says
More than 64,000 pounds of butter have been recalled due to potential undeclared milk allergens, according to the U.S. Food and Drug Administration. Food ingredient company Bunge North America recalled 1,800 cases of its NH European Style Butter Blend that were distributed at 12 centers located across the United States and one in Dominican Republic, a July 14 FDA alert reported. The FDA classified the recall under its second-highest risk warning on July 31 warning that consumption could pose temporary or medically reversible adverse health consequences. USA TODAY has reached out to Bunge North America for comment. Based in Chesterfield, Missouri, Bunge North America is an agribusiness that produces and markets multiple food ingredients including corn, wheat, rice, soybeans and feed peas. Which butter products are recalled? The FDA has issued a recall for 64,800 pounds of Bunge North America's NH European Style Butter Blend with: UPC code: 1 00 78684 73961 2 Lot code: 5064036503 The product was packaged in white paperboard cases each containing 36 blocks. This story has been updated to resolve an inaccuracy in the headline. This article originally appeared on USA TODAY: More than 64,000 pounds of butter recalled over undeclared milk: FDA Solve the daily Crossword
